BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Testolactone

An antineoplastic agent that is a derivative of progesterone and used to treat advanced breast cancer.

123+ PubMed studies analyzed · 11 RCTs · Evidence Score: 47.5

Research Domains

Testolactone has been studied across 15 research domains including 🧬 Hormones, 💪 Strength & Power, ♀♂ Sexual Health, 👁️ Vision & Eye, 🔬 Oncology. The primary research focus is 🧬 Hormones with 63% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Testolactone, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

endoxifen
2 shared targets
dibekacin
2 shared targets
mezlocillin
2 shared targets
Allylestrenol
2 shared targets
Metipranolol
2 shared targets
Tomatine
3 shared targets
Arsenic
2 shared targets
Azaserine
2 shared targets
Epitestosterone
2 shared targets
auricularum
2 shared targets
Loading evidence profile...

This evidence profile for Testolactone is generated deterministically from 123 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.